Request Your Free Playbook Now:

"Why Drug Developers Are Going Digital to Support Therapeutic Launches"

In this playbook, you’ll learn about five ways digital health solutions are flattening barriers to drug access throughout the treatment lifecycle.

Gone are the days when effective new medicines could expect to find organic commercial success. With nearly 30% of drug launches failing to meet expectations and an increasingly competitive market, pharmaceutical leaders are adopting new strategies to help patients find and access best-fit treatments.

By doing so, today’s digital health solutions are changing the very definition of “medical treatment.” Some digital companion apps are clinically validated and insurance-reimbursable, created to be taken alongside drugs, simplifying administration and improving adherence. Their unregulated counterparts are educating patients, supporting providers and advancing the progress of scientific research. All are part of a revolution in connected care, where digital tools are helping:

• Identify prospective patients earlier
• Improve adherence and reduce patient leakage
• Map treatment progress and symptoms

Offered Free by: BioPharma Dive's studioID and Aptar Digital Health
See All Resources from: BioPharma Dive's studioID and Aptar Digital Health